Search research articles
Contact Us
Filters
Showing results (61-70 of 63) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 63 results.
Lancet (London, England)
|
April 20, 2004
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study
F van Leth, P Phanuphak, K Ruxrungtham, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
November 28, 2006
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors
K Deforche, R Camacho, Z Grossman, et al.
Nature Genetics
|
October 15, 1998
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
A J Coffey, R A Brooksbank, O Brandau, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 63) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 63 results.
Lancet (London, England)
|
April 20, 2004
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study
F van Leth, P Phanuphak, K Ruxrungtham, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
November 28, 2006
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors
K Deforche, R Camacho, Z Grossman, et al.
Nature Genetics
|
October 15, 1998
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
A J Coffey, R A Brooksbank, O Brandau, et al.
Page
of 7